ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,739,000 | +9.8% | 1,876,137 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $2,494,000 | -16.8% | 1,756,801 | +2.6% | 0.00% | -50.0% |
| Q3 2016 | $2,996,000 | +3.4% | 1,712,260 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $2,898,000 | -12.0% | 1,695,179 | +1.3% | 0.00% | 0.0% |
| Q1 2016 | $3,295,000 | +12.0% | 1,672,885 | +8.0% | 0.00% | 0.0% |
| Q4 2015 | $2,942,000 | +1.3% | 1,549,235 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $2,903,000 | -58.8% | 1,520,222 | +0.2% | 0.00% | -50.0% |
| Q2 2015 | $7,038,000 | +8.2% | 1,516,926 | +1.9% | 0.00% | 0.0% |
| Q1 2015 | $6,505,000 | +45.4% | 1,488,601 | +15.5% | 0.00% | +33.3% |
| Q4 2014 | $4,473,000 | -14.8% | 1,289,246 | +2.9% | 0.00% | 0.0% |
| Q3 2014 | $5,250,000 | -29.0% | 1,253,163 | -0.8% | 0.00% | -40.0% |
| Q2 2014 | $7,399,000 | -3.8% | 1,262,732 | +3.5% | 0.01% | 0.0% |
| Q1 2014 | $7,688,000 | +22.0% | 1,220,413 | +13.2% | 0.01% | +25.0% |
| Q4 2013 | $6,304,000 | +20.3% | 1,077,683 | +8.3% | 0.00% | 0.0% |
| Q3 2013 | $5,242,000 | -26.0% | 994,639 | +8.1% | 0.00% | -33.3% |
| Q2 2013 | $7,084,000 | – | 919,947 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |